Adverse endothelial function and the insulin resistance syndrome

Journal of Internal Medicine

Volumn 247, Issue 4, 2000, Pages 425-431

  Tooke, J E ^a   Hannemann, M M ^b  

^a Sch of Postgraduate Medicine and H   (United Kingdom)

^b NONE

Author keywords

Endothelial function; Foetal insulin hypothesis; Foetal programming; Insulin resistance syndrome

Indexed keywords

CARDIOVASCULAR RISK; DYSLIPIDEMIA; ENDOTHELIUM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW;

ADULT; ANIMALS; BIRTH WEIGHT; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN RESISTANCE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; VASODILATION;

EID: 0034096785     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00671.x     Document Type: Review

References (59)

1. 1 Reaven GM., Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. 2 Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997: 46 (Suppl. 2): S9-13.
3. 3 Tooke JE, Goh K. Endotheliopathy precedes type 2 diabetes. Diabetes Care 1998; 21: 2047-9.
4. 4 Yki-Jarvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 1995; 38: 1378-88.
5. 5 Morris AD, Petrie JR, Connell JM. Insulin and hypertension. J Hypertension 1994; 12 (6): 633-42.
6. 6 Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7.
7. 7 Despres JP. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obesity Res 1998; 6 (Suppl. 1): 8S-17S.
8. 8 Taskinen MR. Insulin resistance and lipoprotein metabolism. Current Opinion Lipidology 1995; 6 (3): 153-60.
9. 9 Pimenta W, Korytkowski M, Mitrakou A, et al. Pancreatic Beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. Jama 1995; 273: 1855-61.
10. 10 Cahill GF Jr. Beta-cell deficiency, insulin resistance, or both? N Engl J Med 1988; 318: 1268-9.
11. 11 Zimmermann S, Phillips RA, Dunaif A, et al. Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 1992; 75: 508-13.
12. 12 Tsutsu N, Nunoi K, Kodama T, Nomiyama R, Iwase M, Fujishima M. Lack of associalion between blood pressure and insulin in patients with insulinoma. J Hypertension 1990; 8 (5): 479-82.
13. 13 Jiang Z, King G. Direct demonstration of selective insulin resistance on PI3-inase pathway in vascular tissues of obese Zucker (fa/fa) rats. Diabetes 1997; 46 (Suppl 1): 54A.
14. 14 Barker DJP, Hales CN, Fall CHD. Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-7.
15. 15 Barker DJ, Fall CH. Fetal and infant origins of cardiovascular disease. Arch Dis Childhood 1993; 68 (6): 797-9.
16. 16 Phillips DIW, Barker DJP, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia 1994; 37: 150-4.
17. 17 Petry CJ, Ozanne SE, Wang CL, Hales CN. Early protein restriction and obesity independently induce hypertension in 1-year-old rats. Clin Sci 1997; 93 (2): 147-52.
18. 18 Burns SP, Desai M, Cohen RD, et al. Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation. J Clin Investigation 1997; 100 (7): 1768-74.
19. 19 Ravelli ACJ, van der Meulen JHP, Michels RPJ, Osmond C, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998; 351: 173-7.
20. 20 Stanner SA, Bulmer K, Andres C, et al. Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege study, a cross sectional study. Br Med J 1997; 315 (7119): 1342-8.
21. 21 Kahn HS, Narayan KM, Valdez R. Prenatal exposure to famine and health in later life. Lancet 1998; 351 (9112): 1360-1.
22. 22 Seckl JR. Glucocorticoids and small babies. Quart J Medicine 1994; 87 (5): 259-62.
23. 23 Greenberger PA, Patterson R. The outcome of pregnancy complicated by severe asthma. Allergy Proc 1988; 9 (5): 539-43.
24. 24 Fowden AL, Szemere J, Hughes P, Gilmour RS, Forhead AJ. The effects of cortisol on the growth rate of the sheep fetus during late gestation. J Endocrinol 1996; 151 (1): 97-105.
25. 25 Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CRW. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993; 341: 339-41.
26. 26 Benediktsson R, Calder AA, Edwards CR, Seckl JR. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol 1997; 46 (2): 161-6.
27. 27 Edwards CRW, Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of placental glucorticoid barrier: link between fetal environment and adult hypertension? Lancet 1993; 341: 355-7.
28. 28 Edwards CR, Benediktsson R, Lindsay RS, Seckl JR. 11 beta-Hydroxysteroid dehydrogenases, key enzymes in determining tissue-specific glucocorticoid effects. Steroids 1996; 61 (4): 263-9.
29. 29 Pouliot M-C, Despres J-P, Nadeau A, et al. Visceral obesity in men - associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826-34.
30. 30 Lemieux S, Prud'homme D, Nadeau A, Tremblay A, Bouchard C, Despres JP. Seven-year changes in body fat and visceral adipose tissue in women. Association with indexes of plasma glucose-insulin homeostasis. Diabetes Care 1996; 19 (9): 983-91.
31. 51 Anderson PJ, Chan JC, Chan YL, et al. Visceral fat and cardiovascular risk factors in Chinese NIDDM patients. Diabetes Care 1997; 20 (12):1854-8.
32. 32 Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med 1996; 2 (7): 800-3.
33. 33 Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thrombosis & Haemostasis 1997; 78 (1): 656-60.
34. 34 Winkler G, Lakatos P, Salamon F, et al. Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabetic Med 1999; 16 (3): 207-11.
35. 35 Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19 (4): 972-8.
36. 36 Petty RG, Pearson JD. Endothelium - the axis of vascular health and disease. J R Coll Physicians Lond 1989; 23: 92-102.
37. 37 Luescher TF, Barton M. Biology of the endothelium. Clin Cardiol 1997; 20 (Suppl. 11): 3-10.
38. 38 Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
39. 39 Wollschlager H, Zeiher AM, Drexler H, Just H. Assessment of coronary vasomotor tone in humans. Basic Res Cardiology 1991; 86 (Suppl. 2): 185-91.
40. 40 Zeiher AM, Schachinger V, Saurbier B, Just H. Assessment of endothelial modulation of coronary vasomotor tone: insights into a fundamental functional disturbance in vascular biology of atherosclerosis. Basic Res Cardiology 1994; 89 (Suppl. 1): 115-28.
41. 41 Lind L, Sarabi M, Millgard J. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol 1998; 18 (2): 81-7.
42. 42 Morris SJ, Shore AC. Skin blood flow responses to iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 1996; 496 (2): 531-42.
43. 43 Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematology 1995; 90 (2): 244-8.
44. 44 Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci 1995; 88 (6): 629-33.
45. 45 Pedrinelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344 (8914): 14-8.
46. 46 Rossi M, Taddei S, Fabbri A, et al. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 1997; 29 (3): 406-11.
47. 47 Taddei S, Virdis A, Mattei P, Salvetti A., Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21 (6: Part 2): 929-33.
48. 48 Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-1701.
49. 49 Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest 1994; 93 (1): 50-5.
50. 50 Khan F, Litchfield SJ, Belch JJF. Cutaneous microvascular responses are improved after cholesterol lowering in patients with peripheral vascular disease and hyper-cholesterolaemia. Adv Exp Med Biol 1997; 428: 49-54.
51. 51 Makimattila S, Liu ML, Vakkilainen J, et al. Impaired endothelium-dependent vasodilation in type 2 diabetes: relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999; 22 (6): 973-81.
52. 52 Anastasiou E, Lekakis JP, Alevizaki M, et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 1998; 21 (12): 2111-5.
53. 55 Knock GA, McCarthy AL, Lowy C, Poston L. Association of gestational diabetes with abnormal maternal vascular endothelial function. Br J Obstetrics & Gynaecology 1997; 104 (2): 229-34.
54. 54 Balletshofer B, Rittig K, Enderle M, et al. Disturbed flow-associated brachial artery dilation in glucose tolerant, insulin-resistant first-degree relatives of subjects with type 2 diabetes. Diabetologia 1998; 35 (Suppl. 1): 1212.
55. 55 Lee BC, Shore AC, Humphreys JM, Hatterslet AT, Tooke JE. Vascular function and ageing in subjects with a genetic predisposition to type 2 diabetes. Diabetologia 1999; 42 (Suppl. 1): A325.
56. 56 Tooke JE, Lee BC, Humphreys JM, Hattersley AT, Shore AC. Microvascular function and features of insulin resistance syndrome in healthy adults. Diabetologia 1999; 42 (Suppl. 1): A325.
57. 57 Leeson CPMWP, Cook DG, Donald AE, Papacosta O, Lucas A, Deanfield JE. Flow-mediated dilation in 9-to 11-year-old children. The influence of intrauterine and childhood factors. Circulalion 1997; 96: 2233-8.
58. 58 Martin H. J Vasc Res 1998; 35 (Suppl 2): 41 (Abstract).
59. 59 Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999; 353 (9166): 1789-92.